,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1249267,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,716,C1S,https://ctdbase.org/detail.go?type=gene&acc=716,,,716.0,C1S,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of C1S mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
1,1371409,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,50804,MYEF2,https://ctdbase.org/detail.go?type=gene&acc=50804,,,50804.0,MYEF2,10090,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of MYEF2 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
2,1371410,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,4619,MYH1,https://ctdbase.org/detail.go?type=gene&acc=4619,,,4619.0,MYH1,10090,Mus musculus (house mouse),Chromium hexavalent ion results in decreased expression of MYH1 protein,,,PMID:22552367,https://www.ncbi.nlm.nih.gov/pubmed/22552367,22552367,,
3,1371411,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10090,Mus musculus (house mouse),Chromium hexavalent ion results in decreased expression of MYH6 mrna|map2k7 protein promotes the reaction [chromium hexavalent ion results in decreased expression of MYH6 mrna],,,PMID:19654923,https://www.ncbi.nlm.nih.gov/pubmed/19654923,19654923,,
4,1370987,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,7852,CXCR4,https://ctdbase.org/detail.go?type=gene&acc=7852,,,7852.0,CXCR4,9913,Bos taurus (cattle),"Colforsin results in increased expression of CXCR4 mrna|mifepristone inhibits the reaction [colforsin results in increased expression of CXCR4 mrna]|u 0126 inhibits the reaction [colforsin results in increased expression of CXCR4 mrna]|4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [colforsin results in increased expression of CXCR4 mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [colforsin results in increased expression of CXCR4 mrna]",,,PMID:24784705,https://www.ncbi.nlm.nih.gov/pubmed/24784705,24784705,,
5,1370988,47936,Comparative Toxicogenomics Database (CTD),Forskolin,D005576,Colforsin,https://ctdbase.org/detail.go?type=chem&acc=D005576,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606,Homo sapiens (human),Aminoglutethimide inhibits the reaction [colforsin results in increased expression of CYP11A1 mrna]|metyrapone inhibits the reaction [colforsin results in increased expression of CYP11A1 mrna],,,PMID:16935330,https://www.ncbi.nlm.nih.gov/pubmed/16935330,16935330,,
6,1371145,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,771,CA12,https://ctdbase.org/detail.go?type=gene&acc=771,,,771.0,CA12,7955,Danio rerio (zebrafish),Raloxifene hydrochloride results in decreased expression of CA12 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
7,1371146,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,771,CA12,https://ctdbase.org/detail.go?type=gene&acc=771,,,771.0,CA12,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of CA12 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
8,1371147,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,771,CA12,https://ctdbase.org/detail.go?type=gene&acc=771,,,771.0,CA12,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of CA12 mrna|[raloxifene hydrochloride co-treated with ESR1 protein] results in increased expression of CA12 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
9,1371148,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,771,CA12,https://ctdbase.org/detail.go?type=gene&acc=771,,,771.0,CA12,9606,Homo sapiens (human),Raloxifene hydrochloride results in decreased expression of CA12 mRNA,,,PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/26865669,26865669,,
10,1371149,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,762,CA4,https://ctdbase.org/detail.go?type=gene&acc=762,,,762.0,CA4,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of CA4 mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
11,1371271,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,801,CALM1,https://ctdbase.org/detail.go?type=gene&acc=801,,,801.0,CALM1,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with ESR2 protein] results in decreased expression of CALM1 mRNA,,,PMID:19059307,https://www.ncbi.nlm.nih.gov/pubmed/19059307,19059307,,
12,1371272,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,10486,CAP2,https://ctdbase.org/detail.go?type=gene&acc=10486,,,10486.0,CAP2,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride results in decreased expression of CAP2 mRNA,,,PMID:15576828,https://www.ncbi.nlm.nih.gov/pubmed/15576828,15576828,,
13,1371273,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,824,CAPN2,https://ctdbase.org/detail.go?type=gene&acc=824,,,824.0,CAPN2,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of CAPN2 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
14,1371274,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,29775,CARD10,https://ctdbase.org/detail.go?type=gene&acc=29775,,,29775.0,CARD10,9606,Homo sapiens (human),Raloxifene hydrochloride affects the expression of CARD10 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
15,1372858,54900,Comparative Toxicogenomics Database (CTD),Raloxifene Hydrochloride,D020849,Raloxifene Hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=D020849,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,10116,Rattus norvegicus (Norway rat),Raloxifene hydrochloride affects the expression of CTSB mRNA,,,PMID:16079270,https://www.ncbi.nlm.nih.gov/pubmed/16079270,16079270,,
16,1371412,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,8029,CUBN,https://ctdbase.org/detail.go?type=gene&acc=8029,,,8029.0,CUBN,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CUBN mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
17,1371413,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,797445,CUX1A,https://ctdbase.org/detail.go?type=gene&acc=797445,,,797445.0,cux1a,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CUX1A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
18,1371414,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,23316,CUX2,https://ctdbase.org/detail.go?type=gene&acc=23316,,,23316.0,CUX2,9606,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CUX2 mRNA",,,PMID:19692669,https://www.ncbi.nlm.nih.gov/pubmed/19692669,19692669,,
19,1371415,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,57703,CWC22,https://ctdbase.org/detail.go?type=gene&acc=57703,,,57703.0,CWC22,27706,Micropterus salmoides (largemouth bass),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CWC22 mRNA",,,PMID:20589742,https://www.ncbi.nlm.nih.gov/pubmed/20589742,20589742,,
20,1371416,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,6376,CX3CL1,https://ctdbase.org/detail.go?type=gene&acc=6376,,,6376.0,CX3CL1,9606,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CX3CL1 mRNA",,,PMID:28351761,https://www.ncbi.nlm.nih.gov/pubmed/28351761,28351761,,
21,1371417,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,6376,CX3CL1,https://ctdbase.org/detail.go?type=gene&acc=6376,,,6376.0,CX3CL1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CX3CL1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
22,1371418,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,6376,CX3CL1,https://ctdbase.org/detail.go?type=gene&acc=6376,,,6376.0,CX3CL1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CX3CL1 mRNA",,,PMID:19692669,https://www.ncbi.nlm.nih.gov/pubmed/19692669,19692669,,
23,1371419,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,1524,CX3CR1,https://ctdbase.org/detail.go?type=gene&acc=1524,,,1524.0,CX3CR1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CX3CR1 mRNA",,,PMID:34256052,https://www.ncbi.nlm.nih.gov/pubmed/34256052,34256052,,
24,1370978,66898,DrugBank,2-[N-Cyclohexylamino]ethane sulfonic acid,DB03309,N-cyclohexyltaurine,https://www.drugbank.ca/drugs/DB03309,BE0001890,Cyanovirin-N,https://www.drugbank.ca/bio_entities/BE0001890,P81180,Cyanovirin-N,,,45916,Nostoc ellipsosporum,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
25,1370979,66898,DrugBank,2-[N-Cyclohexylamino]ethane sulfonic acid,DB03309,N-cyclohexyltaurine,https://www.drugbank.ca/drugs/DB03309,BE0003050,Phosphoprotein,https://www.drugbank.ca/bio_entities/BE0003050,P03422,Phosphoprotein,,,11235,Measles virus strain Edmonston,,,,,,,,
26,1370980,67145,Therapeutic Target Database (TTD),"5,5'-Methylenedisalicylic acid",D0J5VK,NSC-622445,https://idrblab.net/ttd/data/drug/details/D0J5VK,T72335,Bacterial Lethal factor (Bact lef),https://idrblab.net/ttd/data/target/details/T72335,P15917,Lethal factor,45025515.0,lef,1392,Bacillus anthracis,Inhibitor,,,,,,,
27,1370981,67150,Therapeutic Target Database (TTD),"1,4-Diethoxybenzene",D07DGS,NSC-2113,https://idrblab.net/ttd/data/drug/details/D07DGS,T52389,Quinone reductase 1 (NQO1),https://idrblab.net/ttd/data/target/details/T52389,P15559,NAD,1728.0,NQO1,9606,Homo sapiens (human),Inhibitor,,,,,,,
28,1370982,67239,Drug Gene Interaction database (DGIdb),"3-Dibenzofurancarboxamide, N-(2,5-dimethoxyphenyl)-2-hydroxy-",,CHEMBL:CHEMBL1561747,https://www.dgidb.org/drugs/chembl:CHEMBL1561747,,GNAS,https://www.dgidb.org/genes/hgnc:4392,,,2778.0,GNAS,9606,Homo sapiens (human),,,,,,,,
29,1370983,67282,BindingDB,2-Bromo-4'-phenylacetophenone,7880,2-bromo-1-(4-phenylphenyl)ethan-1-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7880,862,Glycogen synthase kinase-3 beta [7-25],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=862,G1T8E2,[tau protein] kinase ,,,9986,Oryctolagus cuniculus (rabbit),,IC50 (nM),2500.0,PMID:14561081|DOI:10.1021/jm034108b,https://www.ncbi.nlm.nih.gov/pubmed/14561081|https://doi.org/10.1021/jm034108b,14561081,10.1021/jm034108b,
30,1370984,67316,Therapeutic Target Database (TTD),Salazosulfamide,D05JRZ,NSC-27236,https://idrblab.net/ttd/data/drug/details/D05JRZ,T66665,Prostaglandin G/H synthase 2 (COX-2),https://idrblab.net/ttd/data/target/details/T66665,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),Inhibitor,,,,,,,
31,1370985,67356,Drug Gene Interaction database (DGIdb),Fluphenazine Hydrochloride,,FLUPHENAZINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203207,,UBE2N,https://www.dgidb.org/genes/hgnc:12492,,,7334.0,UBE2N,9606,Homo sapiens (human),,,,,,,,
32,1370986,67356,Drug Gene Interaction database (DGIdb),Fluphenazine Hydrochloride,,FLUPHENAZINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203207,,RAD52,https://www.dgidb.org/genes/hgnc:9824,,,5893.0,RAD52,9606,Homo sapiens (human),,,,,,,,
33,1371869,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,179794,MAX-1,https://ctdbase.org/detail.go?type=gene&acc=179794,,,179794.0,max-1,6239,Caenorhabditis elegans,Mianserin results in decreased expression of MAX-1 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
34,1371870,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,174587,MEC-15,https://ctdbase.org/detail.go?type=gene&acc=174587,,,174587.0,mec-15,6239,Caenorhabditis elegans,Mianserin results in increased expression of MEC-15 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
35,1371871,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,172374,MEI-2,https://ctdbase.org/detail.go?type=gene&acc=172374,,,172374.0,mei-2,6239,Caenorhabditis elegans,Mianserin results in increased expression of MEI-2 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
36,1371872,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,177655,MESP-1,https://ctdbase.org/detail.go?type=gene&acc=177655,,,177655.0,mesp-1,6239,Caenorhabditis elegans,Mianserin results in increased expression of MESP-1 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
37,1371873,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,180739,MFSD-12,https://ctdbase.org/detail.go?type=gene&acc=180739,,,180739.0,mfsd-12,6239,Caenorhabditis elegans,Mianserin results in decreased expression of MFSD-12 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
38,1371874,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,174317,MIG-5,https://ctdbase.org/detail.go?type=gene&acc=174317,,,174317.0,mig-5,6239,Caenorhabditis elegans,Mianserin results in increased expression of MIG-5 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
39,1371875,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,189078,MOC-2,https://ctdbase.org/detail.go?type=gene&acc=189078,,,189078.0,moc-2,6239,Caenorhabditis elegans,Mianserin results in decreased expression of MOC-2 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
40,1371876,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,179218,MPDU-1,https://ctdbase.org/detail.go?type=gene&acc=179218,,,179218.0,mpdu-1,6239,Caenorhabditis elegans,Mianserin results in increased expression of MPDU-1 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
41,1371877,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,3565829,MPST-3,https://ctdbase.org/detail.go?type=gene&acc=3565829,,,3565829.0,mpst-3,6239,Caenorhabditis elegans,Mianserin results in increased expression of MPST-3 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
42,1370832,71905,Comparative Toxicogenomics Database (CTD),Olaquindox,C013168,olaquindox,https://ctdbase.org/detail.go?type=chem&acc=C013168,436870,SYN2A,https://ctdbase.org/detail.go?type=gene&acc=436870,,,436870.0,syn2a,7955,Danio rerio (zebrafish),Olaquindox results in decreased expression of SYN2A mRNA,,,PMID:33111391,https://www.ncbi.nlm.nih.gov/pubmed/33111391,33111391,,
43,1371565,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,9606,Homo sapiens (human),SULT2A1 protein results in increased sulfation of betulin,,,PMID:30776358,https://www.ncbi.nlm.nih.gov/pubmed/30776358,30776358,,
44,1371566,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116,Rattus norvegicus (Norway rat),Betulin inhibits the reaction [ethanol results in increased expression of TGFB1 protein],,,PMID:21172400,https://www.ncbi.nlm.nih.gov/pubmed/21172400,21172400,,
45,1371567,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116,Rattus norvegicus (Norway rat),Betulin inhibits the reaction [ethanol results in increased expression of TIMP1 protein],,,PMID:21172400,https://www.ncbi.nlm.nih.gov/pubmed/21172400,21172400,,
46,1371568,72326,Comparative Toxicogenomics Database (CTD),Betulin,C002503,betulin,https://ctdbase.org/detail.go?type=chem&acc=C002503,7077,TIMP2,https://ctdbase.org/detail.go?type=gene&acc=7077,,,7077.0,TIMP2,10116,Rattus norvegicus (Norway rat),Betulin inhibits the reaction [ethanol results in increased expression of TIMP2 protein],,,PMID:21172400,https://www.ncbi.nlm.nih.gov/pubmed/21172400,21172400,,
47,1371700,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1240,CMKLR1,https://ctdbase.org/detail.go?type=gene&acc=1240,,,1240.0,CMKLR1,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of CMKLR1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
48,1371701,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,406383,CMPK,https://ctdbase.org/detail.go?type=gene&acc=406383,,,406383.0,cmpk,7955,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in decreased expression of CMPK protein,,,PMID:19474218,https://www.ncbi.nlm.nih.gov/pubmed/19474218,19474218,,
49,1371702,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,406383,CMPK,https://ctdbase.org/detail.go?type=gene&acc=406383,,,406383.0,cmpk,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CMPK mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
50,1371703,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,129607,CMPK2,https://ctdbase.org/detail.go?type=gene&acc=129607,,,129607.0,CMPK2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CMPK2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CMPK2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
51,1371704,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84319,CMSS1,https://ctdbase.org/detail.go?type=gene&acc=84319,,,84319.0,CMSS1,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of CMSS1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
52,1371705,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84319,CMSS1,https://ctdbase.org/detail.go?type=gene&acc=84319,,,84319.0,CMSS1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CMSS1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
53,1371706,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,113540,CMTM1,https://ctdbase.org/detail.go?type=gene&acc=113540,,,113540.0,CMTM1,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of CMTM1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
54,1371569,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7280,TUBB2A,https://ctdbase.org/detail.go?type=gene&acc=7280,,,7280.0,TUBB2A,9606,Homo sapiens (human),Rosiglitazone results in decreased expression of TUBB2A mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
55,1371570,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7280,TUBB2A,https://ctdbase.org/detail.go?type=gene&acc=7280,,,7280.0,TUBB2A,10090,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TUBB2A mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
56,1371571,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,10090,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TUBB3 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
57,1371572,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,167838,TXLNB,https://ctdbase.org/detail.go?type=gene&acc=167838,,,167838.0,TXLNB,9940,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in increased expression of TXLNB mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
58,1371573,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,10116,Rattus norvegicus (Norway rat),Rosiglitazone results in increased expression of TXNIP mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
59,1371574,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7314,UBB,https://ctdbase.org/detail.go?type=gene&acc=7314,,,7314.0,UBB,10090,Mus musculus (house mouse),Rosiglitazone affects the expression of UBB protein,,,PMID:21347706,https://www.ncbi.nlm.nih.gov/pubmed/21347706,21347706,,
60,1371575,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7327,UBE2G2,https://ctdbase.org/detail.go?type=gene&acc=7327,,,7327.0,UBE2G2,10116,Rattus norvegicus (Norway rat),Rosiglitazone results in decreased expression of UBE2G2 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
61,1371696,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,9606,Homo sapiens (human),"UCP1 protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of adenosine triphosphate]]|ucp1 protein promotes the reaction [rosiglitazone results in increased expression of FASN protein]|ucp1 protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in increased abundance of fatty acids, nonesterified]]",,,PMID:26670611,https://www.ncbi.nlm.nih.gov/pubmed/26670611,26670611,,
62,1371697,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10090,Mus musculus (house mouse),"[rosiglitazone results in increased susceptibility to norepinephrine] which results in increased expression of UCP1 protein|[rosiglitazone results in increased susceptibility to disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate] which results in increased expression of UCP1 mrna|disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate promotes the reaction [rosiglitazone results in increased expression of UCP1 protein]|disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate promotes the reaction [rosiglitazone results in increased expression of UCP1 mrna]|[rosiglitazone results in increased susceptibility to norepinephrine] which results in increased expression of UCP1 mrna|[rosiglitazone results in increased susceptibility to disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate] which results in increased expression of UCP1 protein",,,PMID:29910772,https://www.ncbi.nlm.nih.gov/pubmed/29910772,29910772,,
63,1371698,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10090,Mus musculus (house mouse),(+)-JQ1 compound inhibits the reaction [[triiodothyronine co-treated with rosiglitazone co-treated with INS1 protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of UCP1 mrna]|[triiodothyronine co-treated with rosiglitazone co-treated with INS1 protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of UCP1 mRNA,,,PMID:26972250,https://www.ncbi.nlm.nih.gov/pubmed/26972250,26972250,,
64,1371699,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10090,Mus musculus (house mouse),PPARGC1A affects the reaction [rosiglitazone results in increased expression of UCP1 protein]|ppargc1a affects the reaction [rosiglitazone results in increased expression of UCP1 mrna],,,PMID:22087241,https://www.ncbi.nlm.nih.gov/pubmed/22087241,22087241,,
65,1371150,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,29760,BLNK,https://ctdbase.org/detail.go?type=gene&acc=29760,,,29760.0,BLNK,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BLNK mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
66,1371151,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,168667,BMPER,https://ctdbase.org/detail.go?type=gene&acc=168667,,,168667.0,BMPER,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BMPER mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
67,1371152,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,646,BNC1,https://ctdbase.org/detail.go?type=gene&acc=646,,,646.0,BNC1,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BNC1 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
68,1371153,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,675,BRCA2,https://ctdbase.org/detail.go?type=gene&acc=675,,,675.0,BRCA2,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BRCA2 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
69,1371154,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,23774,BRD1,https://ctdbase.org/detail.go?type=gene&acc=23774,,,23774.0,BRD1,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BRD1 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
70,1371275,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,685,BTC,https://ctdbase.org/detail.go?type=gene&acc=685,,,685.0,BTC,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BTC mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
71,1371276,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BTG2 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
72,1371277,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,54718,BTN2A3P,https://ctdbase.org/detail.go?type=gene&acc=54718,,,54718.0,BTN2A3P,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BTN2A3P mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
73,1371278,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,699,BUB1,https://ctdbase.org/detail.go?type=gene&acc=699,,,699.0,BUB1,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BUB1 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
74,1371279,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,701,BUB1B,https://ctdbase.org/detail.go?type=gene&acc=701,,,701.0,BUB1B,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BUB1B mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
75,1371280,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,8896,BUD31,https://ctdbase.org/detail.go?type=gene&acc=8896,,,8896.0,BUD31,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BUD31 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
76,1371281,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,28969,BZW2,https://ctdbase.org/detail.go?type=gene&acc=28969,,,28969.0,BZW2,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of BZW2 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
77,1371878,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,29080,CCDC59,https://ctdbase.org/detail.go?type=gene&acc=29080,,,29080.0,CCDC59,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of CCDC59 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
78,1371879,123409,Comparative Toxicogenomics Database (CTD),2-Palmitoylglycerol,C114956,2-palmitoylglycerol,https://ctdbase.org/detail.go?type=chem&acc=C114956,85478,CCDC65,https://ctdbase.org/detail.go?type=gene&acc=85478,,,85478.0,CCDC65,9606,Homo sapiens (human),2-palmitoylglycerol results in increased expression of CCDC65 mRNA,,,PMID:37199045,https://www.ncbi.nlm.nih.gov/pubmed/37199045,37199045,,
79,1946761,10238903,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",19533,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19533,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606,Homo sapiens (human),,IC50 (nM),154.0,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
80,1946762,10238903,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",19533,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19533,4252,Cathepsin B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4252,P07858,Cathepsin B,1508.0,CTSB,9606,Homo sapiens (human),,IC50 (nM),1561.0,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
81,1946763,10238903,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",19533,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19533,2032,Cathepsin K,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2032,P43236,Cathepsin K,100009334.0,CTSK,9986,Oryctolagus cuniculus (rabbit),,IC50 (nM),0.2,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
82,1946764,10238903,BindingDB,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",19533,"(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-sulfamoylphenyl)phenyl]ethyl]amino}pentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19533,2012,Procathepsin L,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2012,P07711,Procathepsin L,1514.0,CTSL,9606,Homo sapiens (human),,IC50 (nM),470.0,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777,10.1016/j.bmcl.2005.12.071,
83,1948408,10313045,Comparative Toxicogenomics Database (CTD),"Iron, isotope of mass 56",D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10116,Rattus norvegicus (Norway rat),[nickel co-treated with iron co-treated with tungsten] results in decreased expression of CYP4A14 mRNA,,,PMID:22198552,https://www.ncbi.nlm.nih.gov/pubmed/22198552,22198552,,
84,1948409,10313045,Comparative Toxicogenomics Database (CTD),"Iron, isotope of mass 56",D007501,Iron,https://ctdbase.org/detail.go?type=chem&acc=D007501,9595,CYTIP,https://ctdbase.org/detail.go?type=gene&acc=9595,,,9595.0,CYTIP,9606,Homo sapiens (human),Iron deficiency results in increased expression of CYTIP mRNA,,,PMID:20368581,https://www.ncbi.nlm.nih.gov/pubmed/20368581,20368581,,
85,1989541,13935165,BindingDB,"(2Z)-but-2-enedioic acid; 9-amino-1H,2H,3H-cyclopenta[b]quinolin-1-ol",9353,"(2Z)-but-2-enedioic acid; 9-amino-1H,2H,3H-cyclopenta[b]quinolin-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=9353,1043,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1043,P37136,Acetylcholinesterase,83817.0,Ache,10116,Rattus norvegicus (Norway rat),,IC50 (nM),5970.0,PMID:2754707|DOI:10.1021/jm00128a024,https://www.ncbi.nlm.nih.gov/pubmed/2754707|https://doi.org/10.1021/jm00128a024,2754707,10.1021/jm00128a024,
86,1989542,13983731,Comparative Toxicogenomics Database (CTD),"4'-Hydroxy-3,5,6,7-tetramethoxyflavone",C559192,4'-hydroxytetramethoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C559192,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),CYP1A1 protein results in increased chemical synthesis of 4'-hydroxytetramethoxyflavone,,,PMID:29626627,https://www.ncbi.nlm.nih.gov/pubmed/29626627,29626627,,
87,1989543,13983731,Comparative Toxicogenomics Database (CTD),"4'-Hydroxy-3,5,6,7-tetramethoxyflavone",C559192,4'-hydroxytetramethoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C559192,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606,Homo sapiens (human),CYP1A2 protein results in increased chemical synthesis of 4'-hydroxytetramethoxyflavone,,,PMID:29626627,https://www.ncbi.nlm.nih.gov/pubmed/29626627,29626627,,
88,1989544,13983731,Comparative Toxicogenomics Database (CTD),"4'-Hydroxy-3,5,6,7-tetramethoxyflavone",C559192,4'-hydroxytetramethoxyflavone,https://ctdbase.org/detail.go?type=chem&acc=C559192,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606,Homo sapiens (human),CYP1B1 protein results in increased chemical synthesis of 4'-hydroxytetramethoxyflavone,,,PMID:29626627,https://www.ncbi.nlm.nih.gov/pubmed/29626627,29626627,,
